Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant Enterococci
Changes in fecal flora were evaluated in 22 healthy volunteers administered oral vancomycin or teicoplanin in 1989–1991 in Belgium. Evaluation of 5 colonies per subject revealed no glycopeptide-resistant enterococci in the predominant flora before glycopeptide administration; however, large numbers...
Saved in:
Published in: | The Journal of infectious diseases Vol. 173; no. 5; pp. 1129 - 1136 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chicago, IL
The University of Chicago Press
01-05-1996
University of Chicago Press Oxford University Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Changes in fecal flora were evaluated in 22 healthy volunteers administered oral vancomycin or teicoplanin in 1989–1991 in Belgium. Evaluation of 5 colonies per subject revealed no glycopeptide-resistant enterococci in the predominant flora before glycopeptide administration; however, large numbers (mostly Enterococcusfaecium) emerged by the end of the study in 14 (64%) of the subjects. Pediococci and lactobacilli also increased in number. In 1992, 40 healthy volunteers and 33 cancer patients were evaluated by plating stool samples directly onto selective media containing vancomycin; low numbers of vancomycin-resistant enterococci (<50 cfulg) were found in 11 (28%) of the 40 and 4 (12%) of the 33 samples, respectively. DNA restriction fragment length polymorphism analysis showed that most isolates were different, but all contained vanA in Tn1546-like elements. These results indicate that vanA and Tn1546-like elements were common in Belgium as early as 1989 and that community-based individuals in that location likely form a major reservoir for glycopeptide-resistant enterococci. |
---|---|
Bibliography: | istex:4BA05363411690A8C89DBF65FB23CEA6C4EE9EB7 ark:/67375/HXZ-565N9B3G-V Current affiliations: Hoffmann-La Roche, Basel, Switzerland (P.VdA.); Marmara University Hospital, Section of Infectious Diseases, Istanbul, Turkey (V.K.). Reprints or correspondence: Dr. Barbara E. Murray, Division of Infectious Diseases, Dept. of Internal Medicine, University of Texas Medical School at Houston, 6431 Fannin, 1.728 JFB, Houston, TX 77030. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0022-1899 1537-6613 |
DOI: | 10.1093/infdis/173.5.1129 |